https://litenews.litegroup.media/ Clear, factual global reporting delivered via a licensed news feed and wire service for publishers and platforms. This RSS feed provides a limited sample; full content feeds and reuse rights are available under licence. en © 2026 NXT Ltd. Content reuse subject to licence. See litegroup.media/reuse-and-licensing/. lite.news, operated by NXT Ltd Thu, 15 Oct 2026 19:55:58 -0000 60 lite News RSS Generator https://litenews.litegroup.media/assets/og-default.jpg https://litenews.litegroup.media/ https://litenews.litegroup.media/space-liintech-s-bee-pc2-module-launched-to-iss-on-spacex-crs-35/ The experiment module launched on October 13, 2026, aboard SpaceX CRS-35 to investigate drug molecule binding in microgravity, according to reports. lite News Desk <hello@litegroup.media> Wed, 14 Oct 2026 18:28:31 -0000 https://lite.news/space-liintech-s-bee-pc2-module-launched-to-iss-on-spacex-crs-35/ health-and-biotech Health & Biotech global Global https://litenews.litegroup.media/mhra-sets-out-strategy-2030-to-modernise-uk-medicines-regulation/ A strategy for modernizing UK medicines regulation by 2030 was published on 14 October 2026, according to the regulator's statement. lite News Desk <hello@litegroup.media> Wed, 14 Oct 2026 14:28:22 -0000 https://lite.news/mhra-sets-out-strategy-2030-to-modernise-uk-medicines-regulation/ health-and-biotech Health & Biotech united-kingdom United Kingdom https://litenews.litegroup.media/viiv-healthcare-names-axmed-as-distributor-for-hiv-medicines-in-over-50-countries/ An agreement was announced on October 12, 2026, appointing Axmed as a distributor for HIV medicines in over 50 countries, according to reports. lite News Desk <hello@litegroup.media> Mon, 12 Oct 2026 20:43:08 -0000 https://lite.news/viiv-healthcare-names-axmed-as-distributor-for-hiv-medicines-in-over-50-countries/ health-and-biotech Health & Biotech global Global https://litenews.litegroup.media/fda-approves-hovilpri-for-drug-resistant-hsv-lesions-in-immunocompromised-adults/ A recent approval details Hovilpri's use for treating drug-resistant HSV lesions in immunocompromised adults, according to the regulator. lite News Desk <hello@litegroup.media> Mon, 12 Oct 2026 11:22:45 -0000 https://lite.news/fda-approves-hovilpri-for-drug-resistant-hsv-lesions-in-immunocompromised-adults/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/kenya-suspends-public-health-staff-hotel-meetings-after-imported-ebola-case/ A statement confirms the first imported Ebola case in Kenya on October 6, 2026. Meetings for public health staff were suspended, according to reports. lite News Desk <hello@litegroup.media> Sat, 10 Oct 2026 18:13:11 -0000 https://lite.news/kenya-suspends-public-health-staff-hotel-meetings-after-imported-ebola-case/ health-and-biotech Health & Biotech global Global https://litenews.litegroup.media/uk-adds-patient-reported-outcomes-resources-to-digital-mental-health-collection/ New resources for patient-reported outcomes were added to the digital mental health collection on October 8, 2026, according to reports. lite News Desk <hello@litegroup.media> Fri, 09 Oct 2026 20:26:51 -0000 https://lite.news/uk-adds-patient-reported-outcomes-resources-to-digital-mental-health-collection/ health-and-biotech Health & Biotech united-kingdom United Kingdom https://litenews.litegroup.media/mhra-expands-guidance-and-initiatives-on-real-world-evidence/ The MHRA launched a Real-World Evidence guidance hub on October 9, 2026, to support regulatory decisions using real-world data, according to reports. lite News Desk <hello@litegroup.media> Fri, 09 Oct 2026 18:01:47 -0000 https://lite.news/mhra-expands-guidance-and-initiatives-on-real-world-evidence/ health-and-biotech Health & Biotech united-kingdom United Kingdom https://litenews.litegroup.media/fda-approves-tukysa-combination-for-her2-positive-breast-cancer/ The FDA approved Tukysa in combination with trastuzumab and pertuzumab for advanced HER2-positive breast cancer, according to Pfizer. lite News Desk <hello@litegroup.media> Thu, 08 Oct 2026 17:49:36 -0000 https://lite.news/fda-approves-tukysa-combination-for-her2-positive-breast-cancer/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/kenya-reports-first-imported-case-of-bundibugyo-ebola/ A traveler from the Democratic Republic of Congo tested positive for Bundibugyo Ebola on October 3, 2026, according to health officials. lite News Desk <hello@litegroup.media> Wed, 07 Oct 2026 15:55:32 -0000 https://lite.news/kenya-reports-first-imported-case-of-bundibugyo-ebola/ health-and-biotech Health & Biotech global Global https://litenews.litegroup.media/fda-approves-jaypirca-for-previously-untreated-cll-and-sll/ The FDA approved Jaypirca for adults with untreated CLL or SLL without 17p deletion, marking it as the first non-covalent BTK inhibitor. lite News Desk <hello@litegroup.media> Sat, 03 Oct 2026 05:10:09 -0000 https://lite.news/fda-approves-jaypirca-for-previously-untreated-cll-and-sll/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-accepts-roche-s-fenebrutinib-application-for-multiple-sclerosis/ A filing describes Roche’s NDA acceptance for fenebrutinib on September 30, 2026, according to the regulator. Priority review status was granted. lite News Desk <hello@litegroup.media> Thu, 01 Oct 2026 00:00:39 -0000 https://lite.news/fda-accepts-roche-s-fenebrutinib-application-for-multiple-sclerosis/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-approves-abbvie-s-juvmo-for-parkinson-s-disease-treatment/ A filing describes the approval of a new treatment for Parkinson's disease, according to the regulator. The decision was made on September 25, 2026. lite News Desk <hello@litegroup.media> Mon, 28 Sep 2026 14:03:36 -0000 https://lite.news/fda-approves-abbvie-s-juvmo-for-parkinson-s-disease-treatment/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-approves-pasatru-for-adults-with-fibrodysplasia-ossificans-progressiva/ The FDA has approved Pasatru for treating heterotopic ossification lesions in adults with fibrodysplasia ossificans progressiva, according to the regulator. lite News Desk <hello@litegroup.media> Fri, 25 Sep 2026 20:29:31 -0000 https://lite.news/fda-approves-pasatru-for-adults-with-fibrodysplasia-ossificans-progressiva/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/galleri-multi-cancer-blood-test-gains-fda-panel-support/ A panel voted 10-0 to endorse the Galleri test for detecting multiple cancers through a single blood sample, according to the regulator. lite News Desk <hello@litegroup.media> Thu, 24 Sep 2026 03:18:17 -0000 https://lite.news/galleri-multi-cancer-blood-test-gains-fda-panel-support/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-approves-lyrfigtu-for-advanced-cholangiocarcinoma/ The FDA approved Lyrfigtu for advanced cholangiocarcinoma on September 23, 2026, targeting FGFR2-altered cases in adults, according to reports. lite News Desk <hello@litegroup.media> Thu, 24 Sep 2026 03:13:01 -0000 https://lite.news/fda-approves-lyrfigtu-for-advanced-cholangiocarcinoma/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/harassment-of-public-health-leaders-documented-in-post-pandemic-studies/ A study found 76% of public health leaders reported harassment post-pandemic. Female officials faced higher rates, according to researchers. lite News Desk <hello@litegroup.media> Wed, 23 Sep 2026 05:45:07 -0000 https://lite.news/harassment-of-public-health-leaders-documented-in-post-pandemic-studies/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-workshop-explores-testosterone-use-in-menopausal-women/ A workshop on testosterone therapy for menopausal women occurred on September 17, 2026. Public input was invited, according to the regulator. lite News Desk <hello@litegroup.media> Wed, 23 Sep 2026 02:44:13 -0000 https://lite.news/fda-workshop-explores-testosterone-use-in-menopausal-women/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/umass-boston-and-boston-sphere-launch-high-school-public-health-initiative/ UMass Boston seniors will teach public health topics in three high schools this fall, marking the first project of the Boston SPHERE coalition. lite News Desk <hello@litegroup.media> Tue, 22 Sep 2026 05:24:36 -0000 https://lite.news/umass-boston-and-boston-sphere-launch-high-school-public-health-initiative/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/fda-approves-moderna-s-mflusiva-mrna-flu-vaccine-for-adults-50/ A filing describes the FDA's approval of Moderna’s mFlusiva flu vaccine for adults 50 and older, according to reports. Distribution includes CVS. lite News Desk <hello@litegroup.media> Mon, 21 Sep 2026 04:21:37 -0000 https://lite.news/fda-approves-moderna-s-mflusiva-mrna-flu-vaccine-for-adults-50/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/amneal-launches-fda-approved-generic-lanreotide-injection/ FDA approved Amneal's lanreotide injection on September 18, 2026. The product launched commercially the same day, according to reports. lite News Desk <hello@litegroup.media> Sun, 20 Sep 2026 01:29:05 -0000 https://lite.news/amneal-launches-fda-approved-generic-lanreotide-injection/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/robert-f-kennedy-jr-addresses-vaccine-policy-at-health-conference/ A health conference featured discussions on vaccine policy, addressing federal actions amid rising measles cases, according to reports. lite News Desk <hello@litegroup.media> Sat, 19 Sep 2026 04:19:17 -0000 https://lite.news/robert-f-kennedy-jr-addresses-vaccine-policy-at-health-conference/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/mumps-outbreak-confirmed-among-san-diego-state-university-athletes/ Five mumps cases have been confirmed among SDSU athletes. Screenings and MMR boosters are being provided to close contacts, according to officials. lite News Desk <hello@litegroup.media> Sat, 19 Sep 2026 01:07:10 -0000 https://lite.news/mumps-outbreak-confirmed-among-san-diego-state-university-athletes/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/virtual-biotech-ai-system-analyzes-clinical-trials-for-drug-discovery/ A system with 37,000 AI agents analyzed over 55,000 clinical trials for drug discovery, according to findings published in Science. lite News Desk <hello@litegroup.media> Fri, 18 Sep 2026 01:15:40 -0000 https://lite.news/virtual-biotech-ai-system-analyzes-clinical-trials-for-drug-discovery/ health-and-biotech Health & Biotech global Global https://litenews.litegroup.media/fda-considers-forecasting-tools-in-clinical-trial-reform-efforts/ The FDA seeks public input on a pilot program to expedite clinical trials, aiming to reduce timelines by six to twelve months, according to reports. lite News Desk <hello@litegroup.media> Thu, 17 Sep 2026 01:37:09 -0000 https://lite.news/fda-considers-forecasting-tools-in-clinical-trial-reform-efforts/ health-and-biotech Health & Biotech united-states United States https://litenews.litegroup.media/senator-cassidy-cites-trump-vaccine-policy-in-measles-deaths-hearing/ During a Senate hearing, Senator Cassidy discussed two measles deaths in Pennsylvania. He addressed vaccine safety with surgeon general nominee Dr. Saphier. lite News Desk <hello@litegroup.media> Thu, 17 Sep 2026 01:11:41 -0000 https://lite.news/senator-cassidy-cites-trump-vaccine-policy-in-measles-deaths-hearing/ health-and-biotech Health & Biotech united-states United States